Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

SakuraBead - pain agnostic treatment for everyone

Obiettivo

At CrannMed we are developing resorbable embolic microspheres to unlock the growing potential of vascular embolization. We call this technology SakuraBead.

Our new approach to the treatment of chronic MSK pain is based on a recent unifying understanding of the mechanism of the disease.
Previously chronic MSK pain was considered to be a wear and tear disease, but recent research suggests that the underlying root cause is a self-propagating chronic inflammatory process. This inflammatory process is characterized by the presence of neo-vessels in the tissue surrounding the site of pain. Deactivation of these neo-vessels via embolization treats the mechanism of action of the disease and disrupts the pain pathway promising years of pain free living. Effectively, our technology can turn off the mechanism of pain by interrupting the inflammatory process that sustains it. The technology has been validated in a human clinical studies focused on knee osteoarthritis which resulted in significant and long term pain relief.

SakuraBead will be the world’s first embolic that can be delivered by direct injection in an outpatient setting. Should the technology achieve its full potential it can replace upwards of 50 million steroid injections per year.
Clinical validation of the technology in expanded anatomical locations is a large part of the project.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-EIC-2025-ACCELERATOR-02

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

CRANNMED LTD
Contributo netto dell'UE
€ 2 366 802,08
Indirizzo
TRUSKEY BARNA
H91XW6Y Galway
Irlanda
PMI
Sì
Regione
Ireland Northern and Western West
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
Nessun dato